Stay updated on Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Page revision updated to v3.4.3; the previous revision v3.4.2 was superseded.
    Difference
    0.1%
    Check dated 2026-03-12T02:22:21.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and an older funding/operating-status notice was removed; these are minor administrative updates that do not affect the study content or how you interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T13:59:33.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added a government funding lapse notice about data currency and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:15:35.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated the study record to display 'Last Update Submitted that Met QC Criteria' with revision v3.4.0. Removed the older label 'Last Update Submitted that met QC Criteria', adjusted capitalization of 'No FEAR Act Data' to 'No FEAR Act data', and updated the revision from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T05:56:46.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Page revision history updated: Revision v3.3.4 added and Revision v3.3.3 removed.
    Difference
    0.1%
    Check dated 2026-01-14T03:18:25.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Added a new Locations section with North Carolina as a study site. Removed the North Carolina Locations entry and the HHS Vulnerability Disclosure link; updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T22:40:15.000Z thumbnail image

Stay in the know with updates to Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.